Allurion Stock (NYSE:ALUR)
Previous Close
$0.71
52W Range
$0.49 - $4.64
50D Avg
$0.68
200D Avg
$1.51
Market Cap
$33.68M
Avg Vol (3M)
$177.76K
Beta
-0.41
Div Yield
-
ALUR Company Profile
Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon) and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. The company is headquartered in Natick, Massachusetts.